Welcome to our dedicated page for RLI SEC filings (Ticker: RLI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RLI Corp.'s SEC filings document a specialty property and casualty insurance holding company with common stock listed on the New York Stock Exchange. Current reports furnish quarterly and annual earnings releases, analyst-call transcripts under Regulation FD, dividend declarations and material events for the company and its insurance operations.
RLI's filings also cover governance and executive compensation through proxy statements, capital-structure matters such as its senior notes due 2036, and registered security details for its common stock. These disclosures frame the company's Casualty, Property and Surety operations, investment income, underwriting performance, board matters and shareholder voting items.
RLI Corp’s chief legal officer, Jeffrey D. Fick, received a grant of stock options covering 7,500 shares of common stock. The options carry an exercise price of $49.88 per share and expire on May 14, 2034. According to the vesting schedule, 20% of the options become exercisable one year after the grant date, with an additional 20% vesting on each anniversary thereafter until fully vested. This is a compensation-related award rather than an open-market purchase or sale.
RLI CORP reported that Chief Financial Officer Aaron Paul Diefenthaler received a grant of stock options. The award covers 40,000 stock options for RLI common stock at an exercise price of $49.88 per share.
These options were granted as compensation and are exercisable on a schedule where 20% of the total can be exercised beginning one year after the grant date and an additional 20% in each following year. After this grant, Diefenthaler holds 40,000 stock options directly, with the options scheduled to expire on May 14, 2034.
RLI Corp chief executive officer Craig W. Kliethermes reported a compensation-related stock option grant. He received options covering 22,500 shares of common stock at an exercise price of $49.88 per share. The options expire on May 14, 2034 and vest in 20% increments annually, beginning one year after the grant date.
RLI CORP director Clark C. Kellogg reported routine equity compensation and related share movements. He received a grant of 2,506 restricted stock units (RSUs), each representing one share of common stock. These RSUs are scheduled to vest 100% on the earlier of the company’s 2027 annual shareholders’ meeting or one year after grant.
Kellogg also exercised 1,681 previously granted RSUs into 1,681 shares of common stock and, through a Directors' Trust, acquired an additional 68 shares attributable to accrued special and regular dividend equivalents on RSUs. Following these transactions, the Directors' Trust holds 1,749 shares of common stock.
RLI Corp director Paul Bennett reported routine equity compensation and related transactions. He received a grant of 2,506 restricted stock units, which are scheduled to vest 100% on the earlier of the RLI Corp 2027 Annual Shareholders' Meeting or one year after the grant date.
Bennett also exercised 1,681 restricted stock units into an equal number of common shares and now holds 9,096.229 common shares indirectly through a Directors' Trust, with ownership reflecting dividend reinvestment. Following these moves, he holds 2,506 restricted stock units directly and no remaining units from the exercised grant.
RLI CORP director Debbie Sharell Roberts reported routine equity compensation activity. She received a grant of 2,506 restricted stock units (RSUs) on May 14, 2026, which convert into an equal number of RLI common shares when they vest.
The filing shows she exercised 1,681 RSUs into 1,681 shares of common stock on May 13, 2026, fully exhausting that RSU award. After related transactions, a Directors' Trust associated with her holds 28,837.066 common shares, including 68 shares reflecting dividend reinvestment. The new 2,506 RSUs are scheduled to vest 100% at the earlier of the 2026 annual shareholders' meeting or one year from grant.
RLI Corp director Susan S. Fleming reported routine equity compensation activity. She received a grant of 2,506 restricted stock units that convert into an equal number of common shares at vesting. On a separate date, 1,681 restricted stock units vested and were exercised into common stock, increasing indirect holdings in a Directors' Trust to 22,674.484 shares. No open‑market purchases or sales were reported.
RLI Corp director Jordan W. Graham reported compensation-related equity activity. He received a grant of 2,506 restricted stock units, and separately exercised 1,681 restricted stock units into common shares. Following these transactions, an associated Directors' Trust holds 118,176.471 shares of common stock, including effects of dividend reinvestment.
RLI Corp director David B. Duclos reported routine equity compensation and related share movements. On May 14, 2026, he received a grant of 3,508 restricted stock units, which will vest 100% on the earlier of the 2027 annual shareholders' meeting or one year after grant.
On May 13, 2026, 2,353 restricted stock units vested into 2,353 shares of common stock, and 135 additional shares were acquired through dividend reinvestment in a Directors' Trust. Following these transactions, Duclos holds 18,522.6869 common shares indirectly through the Directors' Trust and 3,508 unvested restricted stock units directly.
STONE MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
RLI Corp director Michael J. Stone reported equity compensation and related share movements. He received a grant of 2,506 restricted stock units, each representing one share of common stock. Separately, 1,681 restricted stock units vested into 1,681 common shares, and ownership also reflects 68 additional shares from dividend reinvestment.
After these transactions, Stone holds 433,315.5196 shares of RLI common stock directly and 2,506 unvested restricted stock units. The new restricted stock units are scheduled to vest 100% on the earlier of the company’s 2027 Annual Shareholders' Meeting or one year after the grant date. All activity reflects compensation, vesting and reinvestment rather than open-market buying or selling.